Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50

United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$89.25K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$142.37M

$14.01M on a plan · $112.91M straight out of an exercise

Sold at will

$15.45M

267 of 434 sales

Net

−$142.28M

−$15.36M against sales at will